FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973017910> ?p ?o ?g. }

• W2973017910 endingPage "2720" @default.
• W2973017910 startingPage "2714" @default.
• W2973017910 abstract "Aims Type 2 diabetes mellitus (T2DM) is commonly complicated by renal impairment. Polyethylene glycol loxenatide (PEX168) is a novel long‐acting glucagon‐like peptide‐1 receptor agonist for T2DM. PEX168 pharmacokinetics was studied to identify requirements for dose‐modification in T2DM complicated by renal impairment. Methods This was a single‐centre, open‐labelled, parallel‐group, single‐dose, phase I clinical trial of patients with mild and moderate renal impairment, and with or without T2DM. Age‐, sex‐ and body mass index‐matched subjects with normal renal function, and with or without T2DM were recruited as controls. Subjects received a single abdominal subcutaneous injection of PEX168 200 μg. Pharmacokinetic samples were taken at 0, 24, 48, 72, 96, 120, 144, 216, 312, 480, 648 and 720 hours. Results Twenty‐three patients were included in the pharmacokinetics analysis. Vz/F and CL/F were lower in the moderate impairment group than in the other groups. The mean t 1/2 (163 hours) in the moderate impairment group was prolonged compared to the mild impairment (117 hours) and normal (121 hours) groups. AUC 0–inf increased by 13 and 100.7% in patients with mild and moderate renal impairment, respectively. Most adverse events were mild gastrointestinal disorders, with only 1 serious adverse event observed. Conclusion A single dose of 200 μg of PEX168 was in general well tolerated in patients with renal impairment. The in vivo clearance rate of PEX168 in patients with moderate renal impairment is slower than in patients with mild renal impairment and normal renal function and dose adjustment might be required ( ClinicalTrials.org #NCT02467790)." @default.
• W2973017910 created "2019-09-19" @default.
• W2973017910 creator A5000432967 @default.
• W2973017910 creator A5003974512 @default.
• W2973017910 creator A5012613471 @default.
• W2973017910 creator A5013228003 @default.
• W2973017910 creator A5023506532 @default.
• W2973017910 creator A5038783611 @default.
• W2973017910 creator A5040306516 @default.
• W2973017910 creator A5049341927 @default.
• W2973017910 creator A5050748359 @default.
• W2973017910 creator A5053119825 @default.
• W2973017910 creator A5058124369 @default.
• W2973017910 creator A5065610505 @default.
• W2973017910 creator A5069340040 @default.
• W2973017910 creator A5080731377 @default.
• W2973017910 creator A5085521489 @default.
• W2973017910 date "2019-12-01" @default.
• W2973017910 modified "2023-09-25" @default.
• W2973017910 title "Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic study" @default.
• W2973017910 cites W169333368 @default.
• W2973017910 cites W1934604330 @default.
• W2973017910 cites W1969037016 @default.
• W2973017910 cites W1980614842 @default.
• W2973017910 cites W2001097346 @default.
• W2973017910 cites W2039246109 @default.
• W2973017910 cites W2059897529 @default.
• W2973017910 cites W2072480954 @default.
• W2973017910 cites W2121396320 @default.
• W2973017910 cites W2126919962 @default.
• W2973017910 cites W2136268502 @default.
• W2973017910 cites W2140536043 @default.
• W2973017910 cites W2168014297 @default.
• W2973017910 cites W2169818177 @default.
• W2973017910 cites W2301888354 @default.
• W2973017910 cites W2599428142 @default.
• W2973017910 cites W2731349674 @default.
• W2973017910 cites W2766306821 @default.
• W2973017910 cites W2771328536 @default.
• W2973017910 cites W2788713284 @default.
• W2973017910 cites W2809463321 @default.
• W2973017910 cites W4240986128 @default.
• W2973017910 cites W952614140 @default.
• W2973017910 doi "https://doi.org/10.1111/bcp.14091" @default.
• W2973017910 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6955414" @default.
• W2973017910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31396983" @default.
• W2973017910 hasPublicationYear "2019" @default.
• W2973017910 type Work @default.
• W2973017910 sameAs 2973017910 @default.
• W2973017910 citedByCount "7" @default.
• W2973017910 countsByYear W29730179102020 @default.
• W2973017910 countsByYear W29730179102021 @default.
• W2973017910 countsByYear W29730179102022 @default.
• W2973017910 countsByYear W29730179102023 @default.
• W2973017910 crossrefType "journal-article" @default.
• W2973017910 hasAuthorship W2973017910A5000432967 @default.
• W2973017910 hasAuthorship W2973017910A5003974512 @default.
• W2973017910 hasAuthorship W2973017910A5012613471 @default.
• W2973017910 hasAuthorship W2973017910A5013228003 @default.
• W2973017910 hasAuthorship W2973017910A5023506532 @default.
• W2973017910 hasAuthorship W2973017910A5038783611 @default.
• W2973017910 hasAuthorship W2973017910A5040306516 @default.
• W2973017910 hasAuthorship W2973017910A5049341927 @default.
• W2973017910 hasAuthorship W2973017910A5050748359 @default.
• W2973017910 hasAuthorship W2973017910A5053119825 @default.
• W2973017910 hasAuthorship W2973017910A5058124369 @default.
• W2973017910 hasAuthorship W2973017910A5065610505 @default.
• W2973017910 hasAuthorship W2973017910A5069340040 @default.
• W2973017910 hasAuthorship W2973017910A5080731377 @default.
• W2973017910 hasAuthorship W2973017910A5085521489 @default.
• W2973017910 hasBestOaLocation W29730179101 @default.
• W2973017910 hasConcept C112705442 @default.
• W2973017910 hasConcept C126322002 @default.
• W2973017910 hasConcept C126894567 @default.
• W2973017910 hasConcept C159641895 @default.
• W2973017910 hasConcept C197934379 @default.
• W2973017910 hasConcept C71924100 @default.
• W2973017910 hasConcept C90924648 @default.
• W2973017910 hasConceptScore W2973017910C112705442 @default.
• W2973017910 hasConceptScore W2973017910C126322002 @default.
• W2973017910 hasConceptScore W2973017910C126894567 @default.
• W2973017910 hasConceptScore W2973017910C159641895 @default.
• W2973017910 hasConceptScore W2973017910C197934379 @default.
• W2973017910 hasConceptScore W2973017910C71924100 @default.
• W2973017910 hasConceptScore W2973017910C90924648 @default.
• W2973017910 hasIssue "12" @default.
• W2973017910 hasLocation W29730179101 @default.
• W2973017910 hasLocation W29730179102 @default.
• W2973017910 hasLocation W29730179103 @default.
• W2973017910 hasOpenAccess W2973017910 @default.
• W2973017910 hasPrimaryLocation W29730179101 @default.
• W2973017910 hasRelatedWork W2010711991 @default.
• W2973017910 hasRelatedWork W2039736044 @default.
• W2973017910 hasRelatedWork W2067628361 @default.
• W2973017910 hasRelatedWork W2080622936 @default.
• W2973017910 hasRelatedWork W2093874596 @default.
• W2973017910 hasRelatedWork W2392413698 @default.
• W2973017910 hasRelatedWork W2400700397 @default.

• next